Literature DB >> 28038389

Adherence to antiepileptic drugs among diverse older Americans on Part D Medicare.

Kendra Piper1, Joshua Richman2, Edward Faught3, Roy Martin4, Ellen Funkhouser5, Jerzy P Szaflarski6, Chen Dai7, Lucia Juarez8, Maria Pisu9.   

Abstract

INTRODUCTION: Older minority groups are more likely to have poor AED adherence. We describe adherence to antiepileptic drugs (AEDs) among older Americans with epilepsy.
METHODS: In retrospective analyses of 2008-2010 Medicare claims for a 5% random sample of beneficiaries augmented by minority representation, epilepsy cases in 2009 were those with ≥1 claim with ICD-9345.x or ≥2 with 780.3x, and ≥1 AED. New-onset cases had no such claims or AEDs in the year before the 2009 index event. We calculated the Proportion of Days Covered (PDC) (days with ≥1 AED over total follow-up days) and used logistic regression to estimate associations of non-adherence (PDC <0.8) with minority group adjusting for covariates.
RESULTS: Of 36,912 epilepsy cases (19.2% White, 62.5% African American (AA), 11.3% Hispanic, 5.0% Asian and 2% American Indian/Alaskan Native), 31.8% were non-adherent (range: 24.1% Whites to 34.3% AAs). Of 3706 new-onset cases, 37% were non-adherent (range: 28.7% Whites to 40.5% AAs). In adjusted analyses, associations with minority group were significant among prevalent cases, and for AA and Asians vs. Whites among new cases. Among other findings, beneficiaries from high-poverty ZIP codes were more likely to be non-adherent than their counterparts, and those in cost-sharing drug benefit phases were less likely to be non-adherent than those in deductible phases.
CONCLUSION: About a third of older adults with epilepsy have poor AED adherence; minorities are more likely than Whites. Investigations of reasons for non-adherence, and interventions to promote adherence, are needed with particular attention to the effect of cost-sharing and poverty.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adherence; Epilepsy; Medicare; Older adults; Part D coverage

Mesh:

Substances:

Year:  2016        PMID: 28038389      PMCID: PMC5297256          DOI: 10.1016/j.yebeh.2016.10.017

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  27 in total

1.  Variation in antiepileptic drug adherence among older patients with new-onset epilepsy.

Authors:  John E Zeber; Laurel A Copeland; Mary Jo V Pugh
Journal:  Ann Pharmacother       Date:  2010-11-02       Impact factor: 3.154

2.  Psychosocial factors associated with medication adherence in ethnically and socioeconomically diverse patients with epilepsy.

Authors:  Amanda J Shallcross; Danielle A Becker; Anuradha Singh; Daniel Friedman; Rachel Jurd; Jacqueline A French; Orrin Devinsky; Tanya M Spruill
Journal:  Epilepsy Behav       Date:  2015-04-04       Impact factor: 2.937

3.  Racial differences in medication adherence: A cross-sectional study of Medicare enrollees.

Authors:  Ben S Gerber; Young Ik Cho; Ahsan M Arozullah; Shoou-Yih D Lee
Journal:  Am J Geriatr Pharmacother       Date:  2010-04

4.  Health disparities in medication adherence between African-Americans and Caucasians with epilepsy.

Authors:  Ramon Edmundo D Bautista; Catrina Graham; Shahbuddin Mukardamwala
Journal:  Epilepsy Behav       Date:  2011-09-09       Impact factor: 2.937

5.  Socioeconomic deprivation independent of ethnicity increases status epilepticus risk.

Authors:  Richard F M Chin; Brian G R Neville; Catherine Peckham; Angie Wade; Helen Bedford; Rod C Scott
Journal:  Epilepsia       Date:  2008-10-24       Impact factor: 5.864

6.  Modeling epilepsy disparities among ethnic groups in Philadelphia, PA.

Authors:  David C Wheeler; Lance A Waller; John O Elliott
Journal:  Stat Med       Date:  2008-09-10       Impact factor: 2.373

7.  Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.

Authors:  R Edward Faught; Jennifer R Weiner; Annie Guérin; Marianne C Cunnington; Mei Sheng Duh
Journal:  Epilepsia       Date:  2008-10-03       Impact factor: 5.864

8.  Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population.

Authors:  Keith L Davis; Sean D Candrilli; Heather M Edin
Journal:  Epilepsia       Date:  2007-11-21       Impact factor: 5.864

Review 9.  Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults.

Authors:  Marie A Krousel-Wood; Paul Muntner; Tareq Islam; Donald E Morisky; Larry S Webber
Journal:  Med Clin North Am       Date:  2009-05       Impact factor: 5.456

10.  Validation of diagnostic codes within medical services claims.

Authors:  Machelle Wilchesky; Robyn M Tamblyn; Allen Huang
Journal:  J Clin Epidemiol       Date:  2004-02       Impact factor: 6.437

View more
  7 in total

Review 1.  Update on Medication Use Quality and Safety in Older Adults, 2017.

Authors:  Shelly L Gray; Zachary A Marcum; Kenneth E Schmader; Joseph T Hanlon
Journal:  J Am Geriatr Soc       Date:  2018-11-13       Impact factor: 5.562

2.  High health care costs in minority groups of older US Medicare beneficiaries with epilepsy.

Authors:  Maria Pisu; Joshua Richman; Jerzy P Szaflarski; Ellen Funkhouser; Chen Dai; Lucia Juarez; Edward Faught; Roy C Martin
Journal:  Epilepsia       Date:  2019-06-06       Impact factor: 5.864

3.  Adherence to Antiseizure vs Other Medications Among US Medicare Beneficiaries With and Without Epilepsy.

Authors:  Samuel Waller Terman; Wesley T Kerr; Carole E Aubert; Chloe E Hill; Zachary A Marcum; James F Burke
Journal:  Neurology       Date:  2021-12-10       Impact factor: 9.910

4.  Antiseizure medication adherence trajectories in Medicare beneficiaries with newly treated epilepsy.

Authors:  Samuel W Terman; Wesley T Kerr; Zachary A Marcum; Lu Wang; James F Burke
Journal:  Epilepsia       Date:  2021-08-31       Impact factor: 5.864

5.  Changes in the Use of Brand Name and Generic Medications and Total Prescription Cost Among Medicare Beneficiaries With Epilepsy.

Authors:  Samuel Waller Terman; Chun C Lin; Wesley T Kerr; Lindsey B DeLott; Brian C Callaghan; James F Burke
Journal:  Neurology       Date:  2022-06-15       Impact factor: 11.800

6.  Quality of Antiepileptic Treatment Among Older Medicare Beneficiaries With Epilepsy: A Retrospective Claims Data Analysis.

Authors:  Maria Pisu; Joshua Richman; Kendra Piper; Roy Martin; Ellen Funkhouser; Chen Dai; Lucia Juarez; Jerzy P Szaflarski; Edward Faught
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

7.  Factors associated with medication adherence in older patients: A systematic review.

Authors:  Ashley Smaje; Maryse Weston-Clark; Ranjana Raj; Mine Orlu; Daniel Davis; Mark Rawle
Journal:  Aging Med (Milton)       Date:  2018-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.